touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Immunotherapy for early-stage, resectable NSCLC

    Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

    The expert

    • Prof. Heather A Wakelee – Stanford University, CA, USA

    This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.


    For further information visit our website:
    https://touchrespiratoryime.org/io-early-stage-nsclc/ 

    35 min
  • Immunotherapy for early-stage, resectable NSCLC

    Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

    The expert

    • Prof. Heather A Wakelee – Stanford University, CA, USA

    This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.


    For further information visit our website:
    https://touchoncologyime.org/io-early-stage-nsclc/

    35 min
  • Impact of pharmacotherapies for achondroplasia – Discussion 4 / 4

    touchMDT for touchENDOCRINOLOGY

    Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia

    The multidisciplinary team and patient advocate:

    MFM specialist - Prof. Karin Blakemore

    Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

    Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

    Paediatrician - Prof. Janet Legare

    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Patient advocate - Ms Carly Kutner

    Freehold, NJ, USA

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

    20 min
  • Monitoring and early treatment initiation - Discussion 3

    touchMDT for touchENDOCRINOLOGY

    Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications

    The multidisciplinary team and patient advocate:

    Paediatrician - Prof. Janet Legare

    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

    Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

    Patient advocate - Ms Carly Kutner

    Freehold, NJ, USA

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

    14 min
  • Early recognition of achondroplasia – Discussion 2 / 4

    touchMDT for touchENDOCRINOLOGY

    Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications.

    The multidisciplinary team and patient advocate:

    Paediatrician - Prof. Janet Legare

    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    MFM specialist - Prof. Karin Blakemore

    Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

    Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

    Patient advocate - Ms Carly Kutner

    Freehold, NJ, USA

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

    17 min
  • MDT management of achondroplasia – Discussion 1 / 4

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals

    The multidisciplinary team:

    Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

    Otto-von-Guericke University Magdeburg, Magdeburg, Germany  

    MFM specialist - Prof. Karin Blakemore

    Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Paediatrician - Prof. Janet Legare

    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

    15 min
  • Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape

    touchEXPERT OPINIONS for touchONCOLOGY

    In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice.

    The expert

    • Prof. Thomas Powles, Barts Cancer Centre, London, UK

    This touchPODCAST is for HCPs outside of the UK and USA only.

    This activity is jointly funded by an independent medical education grant from Astellas Pharma Inc. and Seagen Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: 

    https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape

    33 min
  • Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer

    touchEXPERT OPINIONS for touchONCOLOGY

    A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.

    The expert

    • Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic

    This touchPODCAST is for HCPs outside of the UK only.


    This activity is funded by an independent medical education grant from Merck & Co, Inc.  This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: 

    https://touchoncologyime.org/immunotherapy-in-endometrial-cancer/

    40 min
  • Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

    touchEXPERT OPINIONS for touchIMMUNOLOGY

    Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.

    The experts

    • Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
  • Dr Howard J Huang –  Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
  • Dr Aldo Iacono –  Hofstra University/Northwell Health, Hempstead, NY, USA

    • This touchPODCAST is for HCPs outside of the UK only.

    This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website:

    touchimmunologyime.org/eo-management-of-bos

    33 min
  • Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

    touchEXPERT OPINIONS for touchRESPIRATORY

    Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.

    The experts

    • Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
  • Dr Howard J Huang –  Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
  • Dr Aldo Iacono –  Hofstra University/Northwell Health, Hempstead, NY, USA

    • This touchPODCAST is for HCPs outside of the UK only.

    This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website:

    touchrespiratoryime.org/eo-management-of-bos

    33 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.